Acera Surgical
MO - St. LouisBiotechnology
Focus: Acera Surgical is a biotechnology company specializing in nanofiber technology for soft tissue repair, based in St. Louis, MO with a focused pipeline in diabetic foot ulcers and oncology-adjacent applications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Acera Surgical
AI assessmentNot HiringNo open roles listed right now. Follow Acera Surgical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Synthetic Hybrid-Scale Fiber Matrix
Diabetic Foot UlcerClinical Trials (1)
NCT04927702Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers (DFU) and With Living Cellular Skin Substitute in Treating Venous Leg Ulcers (VLU)
N/AHelp build intelligence for Acera Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.